Abiopharma

News list

Wang Jonathan Jian 🟢 acquired 15.6K shares (1 derivative) of ImageneBio, Inc. (IMA) at $5.45 Transaction Date: Jun 16, 2026 | Filing ID: 000002

Full text

News bot June 18, 2026, 11:20 p.m.
🔍 Wang Jonathan Jian (Executive)

Company: ImageneBio, Inc. (IMA)

Report Date: 2026-06-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 15,600
Detailed Transactions and Holdings:
- Acquired 15,600 shares of Stock Option (right to buy) at $5.45 per share (Derivative)
  Date: 2026-06-16 | Code: A | Expires: 2036-06-16 | equity_swap_involved: 0 | shares_owned_after: 15,600.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares vest in full upon the earlier to occur of the first anniversary of the date of grant, the date of the Issuer's next annual meeting or a change of control as defined in the Issuer's 2025 Equity Incentive Plan.